Table 3.
Standardized Annual Estimates of Costs in 2010 Dollars for Elevated BMI and Pediatric Pre-Hypertension and Hypertension, Controlling for Comorbidity (N=208,800 child-years)
| Inpatient Mean (SE) |
Outpatient Mean (SE) |
Pharmacy Mean (SE) |
Total Mean (SE) |
|
|---|---|---|---|---|
| BMI percentile | ||||
| BMI < 85 | 79 (3) | 558 (4) | 211 (5) | 847 (10) |
| 85<= BMI<95a | 78 (5) | 591 (7) | 234 (11) | 918 (20) |
| BMI >= 95b | 79 (4) | 579 (7) | 235 (6) | 897 (12) |
| Pediatric Hypertension | ||||
| Normal BP | 64 (3) | 498 (4) | 208 (7) | 772 (12) |
| Pre Hypertensionc | 82 (3) | 594 (5) | 231 (5) | 913 (10) |
| Hypertensionc | 171 (17) | 1158 (42) | 262 (9) | 1624 (54) |
Notes:
P-values associated with tests of statistical significance for differences in costs relative to enrollees with BMI under the 85th percentile are .962 for inpatient and <.001 for outpatient, pharmacy, and total costs.
P-values associated with tests of statistical significance for differences in costs relative to enrollees with BMI under the 85th percentile are .870 for inpatient, .006 for outpatient and <.001 for pharmacy and total costs.
P-values associated with tests of statistical significance for differences in costs relative to enrollees with normal BP are <.001 for inpatient, outpatient, pharmacy, and total costs.